|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 7 of 16 found articles
| Title: |
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers |
| Author: |
Felip, Enriqueta Moreno, Victor Morgensztern, Daniel Curigliano, Giuseppe Rutkowski, Piotr Trigo, José Manuel Calvo, Aitana Kowalski, Dariusz Cortinovis, Diego Plummer, Ruth Maio, Michele Ascierto, Paolo A. Vladimirov, Vladimir I. Cervantes, Andres Zudaire, Enrique Hazra, Anasuya T’jollyn, Huybrecht Bandyopadhyay, Nibedita Greger, James G. Attiyeh, Edward Xie, Hong Calvo, Emiliano |
| Appeared in: |
Cancer, chemotherapy and pharmacology |
| Paging: | Volume 89 () nr. 4 pages 499-514 |
| Year: |
2022-03-17 |
| Contents: | |
| Publisher: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 7 of 16 found articles
| << previous | next >> |